Journal of Lipid Research, Vol 35, 291-300, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

High density lipoproteins with differing apolipoproteins: relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase

HO Mowri, JR Patsch, A Ritsch, B Foger, S Brown and W Patsch
Department of Medicine, Baylor College of Medicine, Houston, TX 77030.

To gain insight into metabolic determinants of high density lipoproteins (HDL) containing apolipoproteins A-I and A-II (LpA-I/A-II) and those containing A-I, but devoid of A-II (LpA-I), the plasma concentration of LpA-I and LpA-I/A-II within the HDL2 and HDL3 density spectrum was measured in 14 normolipidemic male subjects on a standardized diet. Apolipoprotein plasma concentrations of HDL subspecies were compared with the magnitude of postprandial lipemia, activities of lipoprotein lipase and hepatic lipase in postheparin plasma, plasma lecithin:cholesterol acyltransferase (LCAT) activity, and cholesteryl ester transfer protein (CETP) mass. Plasma levels of LpA-I/A-II were 2.5 times higher than levels of LpA-I (123 +/- 20 vs. 48.3 +/- 22.1 mg protein/dl) and the partition of LpA-I and LpA-I/A-II between HDL2 and HDL3 differed in that the proportion of LpA-I associated with HDL2 was greater than that of LpA-I/A-II (23 +/- 19 vs. 6 +/- 6%, P < 0.002). With increasing levels of HDL2, the proportion of LpA-I in HDL2 increased (P < 0.002). Furthermore, levels of LpA-I and LpA-I/A-II were strongly correlated within the HDL2 but not within the HDL3 density region. Plasma levels of LpA-I, but not LpA-I/A-II, were inversely correlated with the magnitude of postprandial lipemia. However, activities of lipoprotein lipase and hepatic lipase tended to show stronger associations with the partition of LpA-I/A-II between HDL2 and HDL3 than with that of LpA-I. Within the HDL3, but not the HDL2 density spectrum, LpA-I/A-II exhibited a positive association with plasma LCAT activity, while LpA-I displayed an inverse association with plasma CETP mass. These results are consistent with differences in substrate properties of LpA-I and LpA-I/A-II for lipoprotein modifying enzymes and imply different, but overlapping metabolic pathways of LpA- I and LpA-I/A-II.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. S. Volek, M. J. Sharman, A. L. Gomez, T. P. Scheett, and W. J. Kraemer An Isoenergetic Very Low Carbohydrate Diet Improves Serum HDL Cholesterol and Triacylglycerol Concentrations, the Total Cholesterol to HDL Cholesterol Ratio and Postprandial Lipemic Responses Compared with a Low Fat Diet in Normal Weight, Normolipidemic Women J. Nutr., September 1, 2003; 133(9): 2756 - 2761. [Abstract] [Full Text] [PDF]

				C. J. Stamler, D. Breznan, T. A-M. Neville, F. J. Viau, E. Camlioglu, and D. L. Sparks Phosphatidylinositol promotes cholesterol transport in vivo J. Lipid Res., August 1, 2000; 41(8): 1214 - 1221. [Abstract] [Full Text]

				P. J. Pussinen, M. Jauhiainen, J. Metso, L. E. Pyle, Y. L. Marcel, N. H. Fidge, and C. Ehnholm Binding of phospholipid transfer protein (PLTP) to apolipoproteins A-I and A-II: location of a PLTP binding domain in the amino terminal region of apoA-I J. Lipid Res., January 1, 1998; 39(1): 152 - 161. [Abstract] [Full Text]

				N. Helbecque, J. Dallongeville, V. Codron, D. Arveiler, J.-B. Ruidavets, A. Evans, F. Cambien, J.-C. Fruchart, and P. Amouyel The Role of a Triplet Repeat Sequence of the Very Low Density Lipoprotein Receptor Gene in Plasma Lipid and Lipoprotein Level Variability in Humans Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2759 - 2764. [Abstract] [Full Text]

				M. Tilly-Kiesi, A. H. Lichtenstein, J. M. Ordovas, G. Dolnikowski, R. Malmstrom, M.-R. Taskinen, and E. J. Schaefer Subjects With ApoA-I(Lys107->0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 873 - 880. [Abstract] [Full Text]

				B. Foger, A. Ritsch, A. Doblinger, H. Wessels, and J. R. Patsch Relationship of Plasma Cholesteryl Ester Transfer Protein to HDL Cholesterol: Studies in Normotriglyceridemia and Moderate Hypertriglyceridemia Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1430 - 1436. [Abstract] [Full Text]

				R. McPherson, G. Agnani, P. Lau, J.-C. Fruchart, A. D. Edgar, and Y. L. Marcel Role of Lp A-I and Lp A-I/A-II in Cholesteryl Ester Transfer Protein–Mediated Neutral Lipid Transfer: Studies in Normal Subjects and in Hypertriglyceridemic Patients Before and After Fenofibrate Therapy Arterioscler. Thromb. Vasc. Biol., November 1, 1996; 16(11): 1340 - 1346. [Abstract] [Full Text]

				H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 755 - 762. [Abstract] [Full Text]

				E. Cavallero, F. Brites, B. Delfly, N. Nicolaiew, C. Decossin, C. De Geitere, J.-C. Fruchart, R. Wikinski, B. Jacotot, and G. Castro Abnormal Reverse Cholesterol Transport in Controlled Type II Diabetic Patients : Studies on Fasting and Postprandial LpA-I Particles Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2130 - 2135. [Abstract] [Full Text]